BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 3418508)

  • 21. Population pharmacokinetics of long-term oral amiodarone therapy.
    Pollak PT; Bouillon T; Shafer SL
    Clin Pharmacol Ther; 2000 Jun; 67(6):642-52. PubMed ID: 10872646
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Altered dose-to-effect of propofol due to pharmacokinetics in rats with experimental diabetes mellitus.
    Leal N; Calvo R; Agrad FZ; Lukas JC; de la Fuente L; Suarez E
    J Pharm Pharmacol; 2005 Mar; 57(3):317-25. PubMed ID: 15807987
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interspecies scaling of the pharmacokinetics of N-nitrosodimethylamine.
    Gombar CT; Harrington GW; Pylypiw HM; Anderson LM; Palmer AE; Rice JM; Magee PN; Burak ES
    Cancer Res; 1990 Jul; 50(14):4366-70. PubMed ID: 2364390
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Changes in thyroid state affect pHi and Nai+ homeostasis in rat ventricular myocytes.
    Wolska BM; Averyhart-Fullard V; Omachi A; Stojanović MO; Kallen RG; Solaro RJ
    J Mol Cell Cardiol; 1997 Oct; 29(10):2653-63. PubMed ID: 9344760
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of experimental hypo- and hyperthyroidism on serum adiponectin.
    Aragão CN; Souza LL; Cabanelas A; Oliveira KJ; Pazos-Moura CC
    Metabolism; 2007 Jan; 56(1):6-11. PubMed ID: 17161219
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Absorption, disposition kinetics, and metabolic pathways of cyclohexene oxide in the male Fischer 344 rat and female B6C3F1 mouse.
    Sauer JM; Bao J; Smith RL; McClure TD; Mayersohn M; Pillai U; Cunningham ML; Sipes IG
    Drug Metab Dispos; 1997 Mar; 25(3):371-8. PubMed ID: 9172957
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The pharmacokinetics of 1,2-diethyl-3-hydroxypyridin-4-one (CP94) in rats.
    Epemolu OR; Singh S; Hider RC; Damani LA
    Drug Metab Dispos; 1992; 20(5):736-41. PubMed ID: 1358580
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Thymidine kinase activity in homogenates of rat thyroid lobes from euthyroid, hypothyroid and/or hyperthyroid rats incubated with EGF: studies ex vivo in vitro.
    Karbownik M; Modrzejewska H; Gesing A; Greger J; Lewinski A
    Endocr Regul; 1999 Mar; 33(1):17-23. PubMed ID: 10200584
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of thyroid dysfunction on propranolol kinetics.
    Riddell JG; Neill JD; Kelly JG; McDevitt DG
    Clin Pharmacol Ther; 1980 Nov; 28(5):565-74. PubMed ID: 7438675
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacokinetics of coumarin and 7-hydroxycoumarin upon i.v. and p.o. administration in the euthyroid and hypothyroid beagle dog.
    Ritschel WA; Grummich KW
    Arzneimittelforschung; 1981; 31(4):643-9. PubMed ID: 7195711
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Influence of mild thyroid dysfunction on antipyrine clearance and metabolite formation in man.
    Teunissen MW; van der Veen EA; Doodeman PJ; Breimer DD
    Eur J Clin Pharmacol; 1984; 27(1):99-103. PubMed ID: 6489432
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Toxicokinetics and bioavailability of oral and intravenous 1,1-dichloroethylene.
    Putcha L; Bruckner JV; D'Souza R; Desai F; Feldman S
    Fundam Appl Toxicol; 1986 Feb; 6(2):240-50. PubMed ID: 3699314
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vasopressin and oxytocin release and the thyroid function.
    Ciosek J; Drobnik J
    J Physiol Pharmacol; 2004 Jun; 55(2):423-41. PubMed ID: 15213363
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacokinetics and disposition of the oxytocin receptor antagonist L-368,899 in rats and dogs.
    Thompson KL; Vincent SH; Miller RR; Colletti AE; Alvaro RF; Wallace MA; Feeney WP; Chiu SH
    Drug Metab Dispos; 1997 Oct; 25(10):1113-8. PubMed ID: 9321512
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Myocardial disposition of amiodarone in the dog.
    Latini R; Connolly SJ; Kates RE
    J Pharmacol Exp Ther; 1983 Mar; 224(3):603-8. PubMed ID: 6827483
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of thyroid state on the expression of hepatic thyroid hormone transporters in rats.
    Peeters RP; Friesema EC; Docter R; Hennemann G; Visser TJ
    Am J Physiol Endocrinol Metab; 2002 Dec; 283(6):E1232-8. PubMed ID: 12388169
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tissue distribution of amiodarone and desethylamiodarone in rats after repeated oral administration of various amiodarone dosages.
    Plomp TA; Wiersinga WM; Maes RA
    Arzneimittelforschung; 1985; 35(12):1805-10. PubMed ID: 4096733
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Influence of thyroid hormones on collagen content in tissues of guinea pigs.
    Drózdzm M; Kucharz E; Grucka-Mamczar E
    Endokrinologie; 1979 Feb; 73(1):105-11. PubMed ID: 467355
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Evaluation of the relative biological availability of amiodarone Polfa preparation after extravascular administration of a single dose].
    Paczkowski D; Sadowski Z; Koliński P; Filipek M; Podleśny J
    Kardiol Pol; 1989; 32(6):326-33. PubMed ID: 2632911
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of amiodarone and thyroid dysfunction on myocardial calcium, serum calcium and thyroid hormones in the rat.
    Gammage MD; Franklyn JA; Logan SD
    Br J Pharmacol; 1987 Oct; 92(2):363-70. PubMed ID: 3676598
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.